A Phase I Clinical Study to Assess the Safety and Efficacy of CD70-targeted CAR-T in the Treatment of CD70-positive Advanced/Metastatic Gynecologic Cancer
This is a single-center, double-arm, open-label study. this study plans to evaluate the safety and efficacy of CD70-targeting CAR-T cells in the treatment of CD70-positive advanced/metastatic Gynecologic Cancer, and obtain recommended doses and infusion patterns.
100 项与 CD70阳性女性生殖器官肿瘤 相关的临床结果
100 项与 CD70阳性女性生殖器官肿瘤 相关的转化医学
0 项与 CD70阳性女性生殖器官肿瘤 相关的专利(医药)